top of page
ST. LOUIS – Aegis Digital Health, which commercializes technologies in virtual care such as SweetSpot for diabetes management, today announced that Dr. Mary Jo Gorman has joined its Board of Directors. Aegis Digital Health is a company established through BioGenerator in 2021 and is dedicated to breaking the barriers that limit excellence in patient care.
Gorman is a serial entrepreneur and seasoned executive with extensive experience in telemedicine and virtual care, underscored by her role as founder and CEO of Advanced ICU Care, the largest national telemedicine company in the Intensive Care Unit space. Under her leadership, the company achieved a $40M run rate and successfully raised over $20M in venture capital. Additionally, Dr. Gorman led the Inpatient Care Group, the first hospitalist company in the St. Louis region. After being sold to IPC-The Hospitalist Company, where she served as Chief Medical Officer, the company grew to $110M in revenue and nearly 500 providers in sixteen states. Her strategic vision and leadership have driven significant growth and value creation for our healthcare system.
“Diabetes continues to be a substantial burden on our healthcare system, despite more than 40 new devices and treatments coming to market over the past 15 years,” said Stephen Von Rump, Aegis Digital Health’s CEO. “Mary Jo’s operational experience growing virtual care companies and working with payers, providers, and patients to drive improved outcomes will accelerate our ability to transform the standard of care for diabetes.”
“Mary Jo has an impressive track record as an entrepreneur and as a member of BioGenerator’s investor advisory committee. She is also a passionate booster of our ecosystem” says Donn Rubin, CEO of BioSTL and Chairman of BioGenerator, BioSTL’s startup and investment arm. “We’re delighted she’ll bring her expertise to this important enterprise.”
“Continuous Glucose Monitors and Insulin Delivery Devices offer a significant opportunity to improve glycemic control when utilized to their fullest,” said Dr. Gorman. “SweetSpot is ensuring that all the potential value these devices could deliver is able to be realized by endocrinologists, payers, and patients.”
Aegis Digital Health’s Board of Directors is chaired by Stephen Von Rump, and also includes independent director, David Christenson.
About Aegis Digital Health: Aegis Digital Health commercializes early-stage products and technologies in virtual care and remote patient management. Their first product is SweetSpot, a remote diabetes management platform that integrates with multiple CGM and insulin delivery devices to provide physicians with a single view of their patients’ data. The product includes full clinical support services, including patient consent, onboarding, data review, communications and treatment recommendations, for providers who do not have the resources to do so on their own. About BioSTL: Since 2001, St. Louis nonprofit BioSTL has laid the foundation for the region's innovation economy with a comprehensive set of transformational programs that elevate St. Louis’ leadership in solving important world challenges in agriculture, medicine, health care, and other technology areas. BioSTL has introduced nationally acclaimed initiatives in startup creation and investment (BioGenerator), strategic business attraction (GlobalSTL), physical environment (including the Cortex Innovation District and BioGenerator Labs), entrepreneur support, seed and venture capital, a diverse and inclusive workforce, and public policy.
Media Contact: Joelle Fredman Director of Marketing and Community SweetSpot jfredman@aegisdigitalhealth.com
bottom of page